Health Care Equipment & Services

CEO Dudum Andrew’s 463,289‑share sale of HIMS & HERS HEALTH INC. reveals a strategic portfolio shift, not a loss of confidence, while the company’s obesity‑drug pipeline and regulatory climate shape future upside.

Guardant Health insider moves reveal a subtle shift: CEO Eltoukhy Helmy sells and buys shares while boosting philanthropic trust and advancing liquid biopsy pipeline, signaling steady long‑term confidence.

Mark Hancock’s recent insider selling at PACS Group reveals a strategic portfolio realignment amid a strong market position, raising investor curiosity about future moves.

Insider selling at Hinge Health rises—Robinson Elliott’s recent $92.85 sale signals routine liquidity, not a crisis, while the company’s robust growth keeps investors intrigued.

HealthEquity insider trades show disciplined growth: director buys low, sells near market, reinforcing confidence in its tech‑driven health‑care value.

Insider sale of 56,500 Centene shares by Koster shows routine liquidity moves, not a warning. Stay tuned for earnings to gauge future outlook.

Envista insider sales on 8/25/26 show routine tax‑trigger moves, not distress—dental market stays bullish, product pipeline fuels growth.

Insightful insider selling analysis at OrthoPediatrics: coordinated sales, 3P™ platform launch, market impact, and investor guidance.

Insider selling at Stryker: Group President Crotty Dylan Bram sells 441 shares at $328.61 – what this means for investors and the company’s future.

Insider buy at Vivos Therapeutics raises hopes but also highlights the company’s near‑term risks and uncertain earnings outlook.